|
(PDQ5)Integrated Genetic and Epigenetic Prognostication for Acute Myeloid Leukemi
|
5R21CA185365-02
|
$139,200
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
5R01CA185062-02
|
$312,377
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
(PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation
|
5R21CA184851-02
|
$195,963
|
TROWBRIDGE, JENNIFER
|
JACKSON LABORATORY
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-02
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
1R01CA194596-01
|
$547,017
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
|
5R01CA184922-02
|
$553,684
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
|
5R01CA180037-03
|
$328,888
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
2015 Stem Cells & Cancer Gordon Research Conference & Gordon Research Seminar
|
1R13CA192385-01
|
$2,000
|
ZON, LEONARD
|
GORDON RESEARCH CONFERENCES
|
|
A biochemical companion diagnostic platform to measure kinase inhibitor pharmacod
|
1R41CA186505-01A1
|
$211,754
|
HOBAUGH, MARK
|
MICROFLUIDIC INNOVATIONS, LLC
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 - 02060
|
$164,963
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOM
|
ZIA CP010121 - 10363
|
$46,197
|
Lan, Qing
|
DCEG (NCI)
|
|
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
|
5U01CA174844-03
|
$487,154
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
1R01CA190843-01
|
$325,389
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
5R01CA183252-02
|
$538,425
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Epigenetic Circuit in Acute Leukemia
|
5R21CA187276-02
|
$203,580
|
HUANG, GANG
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A novel hematopoietic stem cell population
|
5F31CA180604-02
|
$47,398
|
BALCEREK, JOANNA
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia
|
1R03CA191983-01A1
|
$79,500
|
LAVAU, CATHERINE
|
DUKE UNIVERSITY
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
5K99CA183914-02
|
$169,668
|
WAN, LIXIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Novel Role for PML bodies in Leukemic Transformation
|
5F32CA189413-02
|
$56,042
|
COGSWELL, ALEXIS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A Pathway of Tumor Suppression
|
5R01CA047296-27
|
$249,580
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVH
|
1R44CA192601-01A1
|
$1,059,489
|
BUI, LYNNE
|
TARGAZYME, INC.
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$247,753
|
Tosato, Giovanna
|
CCR (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,131,149
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
|
5K08CA160660-05
|
$156,330
|
KENTSIS, ALEX
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$522,314
|
Aplan, Peter
|
CCR (NCI)
|
|
Acute Myeloid Leukemia: MRD Analysis Using Modular uFluidics and uFlow Cytometry
|
5R21CA173279-03
|
$146,331
|
SOPER, STEVEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$707,219
|
Fry, Terry
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
5P01CA018029-40
|
$4,225,448
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Advanced development and validation of targeted molecular counting methods for pr
|
1R33CA192980-01
|
$375,858
|
SALIPANTE, STEPHEN
|
UNIVERSITY OF WASHINGTON
|
|
Aging-associated alterations in adaptive landscapes and the evolution of leukemia
|
5R01CA180175-03
|
$345,027
|
DEGREGORI, JAMES
|
UNIVERSITY OF COLORADO DENVER
|
|
Agricultural Cohort Consortium
|
ZIA CP010119 - 10537
|
$74,872
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 - 10527
|
$854,646
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ALL immunobiology and the bone marrow niche
|
ZIA BC 011295
|
$303,094
|
Fry, Terry
|
CCR (NCI)
|
|
ALL therapy and developing brains: MRI measures, genetic factors and cognition
|
5R01CA090246-10
|
$380,224
|
REDDICK, WILBURN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-05
|
$170,100
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$145,193
|
Kochenderfer, James
|
CCR (NCI)
|
|
Alloreactive Regulatory T cells control GVHD and maintain GVL effect
|
5R01CA118116-08
|
$264,033
|
YU, XUE-ZHONG
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
|
5R01CA170250-04
|
$584,002
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125 - 10712
|
$100,308
|
Jones, Rena
|
DCEG (NCI)
|
|
Analysis of Initiating Events in Inv(16) Associated Acute Myeloid Leukemia
|
5R00CA148963-04
|
$249,000
|
HYDE, RICIA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,007,151
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Apoptosome Regulation in Leukemia by Protein Phosphatase 5 Hypoacetylation
|
5F31CA174243-03
|
$33,296
|
FOSS, KRISTEN
|
DUKE UNIVERSITY
|
|
ARID5B and disparities of childhood leukemia
|
3U01CA176063-02S1
|
$98,461
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
ARID5B and disparities of childhood leukemia
|
5U01CA176063-02
|
$377,891
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|